ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 3837 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 3639
1 LEFLUNOMIDE 3547
2 ADALIMUMAB 3532
3 METHOTREXATE 3491
4 TOCILIZUMAB 3459
5 ETANERCEPT 3420
6 INFLIXIMAB 3405
7 CERTOLIZUMAB PEGOL 3348
8 ABATACEPT 3304
9 SULFASALAZINE 3293
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 157 0.4906
1 200 WET WIPES 241 0.4590
2 PSEUDOEPHEDRINE HYDROCHLORIDE 2188 0.4121
3 CETRIMIDE 41 0.4100
4 CAFFEINE CITRATE 458 0.3703
5 PSEUDOEPHEDRINE HCL 2224 0.3540
6 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 79 0.3333
7 CORTISONE ACETATE 2363 0.3154
8 DESOXIMETASONE 3075 0.2656
9 HYDROCORTISONE PROBUTATE 19 0.2603
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 3547 0.0401
1 Interleukin-6 Receptor Antagonist [EPC] 3487 0.0356
2 Aminosalicylate [EPC] 3293 0.0316
3 Selective T Cell Costimulation Modulator [EPC] 3304 0.0305
4 Histamine-1 Receptor Antagonist [EPC] 1036 0.0276
5 Interleukin-12 Antagonist [EPC] 1820 0.0234
6 Endoglycosidase [EPC] 44 0.0165
7 CD20-directed Cytolytic Antibody [EPC] 3207 0.0144
8 Interleukin-23 Antagonist [EPC] 1820 0.0144
9 Vitamin D [EPC] 3220 0.0127
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE